SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Madharry who wrote (1685)7/1/2003 7:05:39 PM
From: Robohogs  Read Replies (1) of 3044
 
If all goes okay, MLNM should get get about $400-500 MM and if this drug goes great against many cancers, $750 MM usinf round numbers. This is for about 1/3 of drug (40-50% of mkt less royalties). That means a value of $1.2-1.5B is likely being used by JNJ with tremendous upside and not counting the value it brings to the table. My interpretation. Given risk level, that would imply it could become worth $3-4 B in a few years ($750 x 3 plus upside for risk return).

Jon
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News